Efficacy and Safety of Tildrakizumab Compared to Placebo in Subjects With Active Psoriatic Arthritis I (INSPIRE 1)

NCT04314544 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

508

Enrollment

INDUSTRY

Sponsor class

Conditions

Active Psoriatic Arthritis

Interventions

DRUG: TILD
DRUG: matching placebo injections

Sponsor

Sun Pharmaceutical Industries Limited